Industry Resources2019-11-21T14:51:21+00:00

Industry Resources

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

DTA Launches Payer Advisory Group

The Digital Therapeutics Alliance is pleased to launch our Healthcare Payer Advisory Group. We are seeking global engagement from individuals who have experience working within healthcare decision maker and payer settings. Advisory Group members will [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

What if we get things right? Visions for 2030

World Economic Forum (Ceri Parker) -- We asked members of our Global Future Councils - academics, business leaders and members of civil society - to imagine a better world in 2030. Only by thinking about where [...]

Load More Posts

DTx Member Companies in the News

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Cognoa Launches Pivotal Study of Diagnostic Aid for Autism

Cognoa, a Palo Alto, CA-based pediatric behavioral health company developing digital medicines, announced the launch of a pivotal study of its digital diagnostic aid for autism. The results of this pivotal study will be the basis for the submission to FDA next year. Study of [...]

Load More Posts

Stay Up To Date


Sign Up Now